Serum Markers for the Noninvasive Diagnosis of Endometriosis
Researchers investigated serum markers for noninvasively diagnosing endometriosis, finding that a panel of biomarkers shows more promise than single markers due to diagnostic challenges with current methods.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (55)
- Accuracy of magnetic resonance imaging and rectal endoscopic sonography for the prediction of location of deep pelvic endometriosis via openalex
- Activin A, Activin Receptor Type II, Nodal, and Cripto mRNA Are Expressed by Eutopic and Ectopic Endometrium in Women With Ovarian Endometriosis via openalex
- Behaviour of Cytokine Levels in Serum and Peritoneal Fluid of Women with Endometriosis via openalex
- Clinical evaluation of CA-125 concentrations as a prognostic factor for pregnancy in infertile women with surgically treated endometriosis via openalex
- Comparison of the clinical value of CA 19-9 versus CA 125 for the diagnosis of endometriosis via openalex
- Comparison of the effects of leuprorelin acetate and danazol treatments on serum CA-125 levels in women with endometriosis. via openalex
- Cytokine and immune cell levels in peritoneal fluid and peripheral blood of women with early- and late-staged endometriosis via openalex
- Deranged expression of follistatin and follistatin-like protein in women with ovarian endometriosis via openalex
- Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis via openalex
- Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifing biomarkers of endometriosis via openalex
- Elevated glycodelin-A concentrations in serum and peritoneal fluid of women with ovarian endometriosis via openalex
- Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis via openalex
- Elevated soluble Fas ligand levels may suggest a role for apoptosis in women with endometriosis via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis via openalex
- Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis via openalex
- Evaluation of serum CA 125 levels in patients with pelvic pain related to endometriosis via openalex
- Evaluation of Serum CA 125 Levels in Patients with Pelvic Pain Related to Endometriosis via openalex
- Expression of Serum Human Leukocyte Antigen and Growth Factor Levels in a Greek Family With Familial Endometriosis via openalex
- Expression of Soluble Adhesion Molecules in Sera of Women With Stage III and IV Endometriosis via openalex
- Haptoglobin β chain isoforms in the plasma and peritoneal fluid of women with endometriosis via openalex
- High serum follistatin levels in women with ovarian endometriosis via openalex
- Identifying biomarkers of endometriosis using serum protein fingerprinting and artificial neural networks via openalex
- Levels of complement components iC3b, C3c, C4, and SC5b-9 in peritoneal fluid and serum of infertile women with endometriosis via openalex
- Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers via openalex
- Original paper CD4 + , CD8 + and CD4 + CD25 + T lymphocytes in peripheral blood and peritoneal fluid of women with endometriosis - preliminary report via openalex
- Peritoneal and Peripheral B‐1‐Cell Populations in Patients with Endometriosis via openalex
- Peritoneal fluid and serum autoantibody levels in patients with endometriosis via openalex
- Plasma Urocortin Levels in the Diagnosis of Ovarian Endometriosis via openalex
- Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial via openalex
- Serum Antiendometrial Antibodies and Diagnosis of Endometriosis via openalex
- Serum CA-125 in preoperative patients at high risk for endometriosis via openalex
- Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis via openalex
- The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres via openalex
- The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis via openalex
- The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis via openalex
- Two novel serum biomarkers for endometriosis screened by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and their change after laparoscopic removal of endometriosis via openalex
- Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response via openalex
- Usefulness and limits of CA-125 in diagnosis of endometriosis without associated ovarian endometriomas via openalex
- Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report via openalex
- W1026598425 via openalex
- W2049037562 via openalex
- W2094067819 via openalex
- W2094889223 via openalex
- W2109755132 via openalex
- W2128928486 via openalex
- W2135721067 via openalex
- W2158516834 via openalex
- W2010793153 via openalex
- W2171863626 via openalex
- W1983947024 via openalex
- W2396544240 via openalex
- W1787839452 via openalex
- W4211081176 via openalex
- W2071999223 via openalex
Cited by (22)
- Detection of activin A and follistatin as potential biomarkers in women with ovarian endometriosis 2026
- Association between serum carotenoids and risk of endometriosis evidence from NHANES data 2025
- Enhancing endometrioma management: Diagnostic biomarkers and predictive outcomes in Ruptured vs. Non-Ruptured cases 2024
- Endometriosis-Associated Infertility: The Role of Biomarkers of Apoptosis and Proliferation in Early Noninvasive Diagnosis 2024
- The Known, the Unknown and the Future of the Pathophysiology of Endometriosis 2024
- Application Progress of Noninvasive Biomarkers in the Diagnosis of Endometriosis 2023
- Multicenter evaluation of blood-based biomarkers for the detection of endometriosis and adenomyosis: A prospective non-interventional study 2023
- Biomarkers of endometriosis 2023
- Non-invasive diagnosis of endometriosis: Immunologic and genetic markers 2022
- Novel methods in diagnosis of endometriosis in future 2022
- Significance of metabolomic disorders in infertility and miscarriage in patients with endometriosis 2022
- Novel Diagnostic Markers for Endometriosis 2021
- The Potential of Non-Invasive Biomarkers for Early Diagnosis of Asymptomatic Patients with Endometriosis 2021
- Metabolomics in endometriosis: challenges and perspectives for future studies 2021
- Application of serum markers in diagnosis and staging of ovarian endometriosis 2021
- The Link Between Stress and Endometriosis: from Animal Models to the Clinical Scenario 2020
- Indicators of activin A in patients with external genital endometriosis. Materials of 15th International Interdisciplinary Congress on Allergology and Immunology (May 22-24, 2019, Moscow) 2019
- Anti-inflammatory cytokines in endometriosis 2019
- O soro de mulheres com endometriose altera os níveis de citocinas produzidas pelas células estromais e endoteliais uterinas cocultivadas em sistema 3D. 2017
- Plasma urocortin-1 as a preoperative marker of endometriosis in symptomatic women 2017
- Environmental Manipulations as an Effective Alternative Treatment to Reduce Endometriosis Progression 2017
- Endometriosis Leads to an Increased Trefoil Factor 3 Concentration in the Peritoneal Cavity but Does Not Alter Systemic Levels 2016
Source provenance
- europepmc
- last seen: 2026-10-06T06:14:42.462031+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:17:39.907309+00:00